Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Ml-18 | 1422269-30-4 | MFCD30182327 | 98.9% | 569.65 g/mol | C32H35N5O5 | 200 MG
SDP

Catalog No. 5000245895
Encompass_Preferred

ML-18 is a small-molecule, non-peptide antagonist of bombesin receptor subtype-3 (BRS-3) used for receptor binding and cellular signaling research. It inhibits BRS-3 binding in cell-based assays with an IC50 of 4.8 μM, shows lower affinity at GRPR (IC50 16 μM), and minimal activity at NMBR (>100 μM).

  • Non-peptide antagonist of BRS-3 for receptor and signaling studies.
  • Validated potency: IC50 4.8 μM at BRS-3.
  • Lower off-target affinity: IC50 16 μM (GRPR), >100 μM (NMBR).
  • Chemical formula C32H35N5O5; molecular weight 569.65 g/mol.
  • High purity solid (98.87%), available in solid and DMSO solution formats.

Catalog No. 50-002-45895 Supplier Medchemexpress LLC Supplier No. HY101844200MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

ML-18 is a small-molecule, non-peptide antagonist of bombesin receptor subtype-3 (BRS-3) used for receptor binding and cellular signaling research. It inhibits BRS-3 binding in cell-based assays with an IC50 of 4.8 μM, shows lower affinity at GRPR (IC50 16 μM), and minimal activity at NMBR (>100 μM).

  • Non-peptide antagonist of BRS-3 for receptor and signaling studies.
  • Validated potency: IC50 4.8 μM at BRS-3.
  • Lower off-target affinity: IC50 16 μM (GRPR), >100 μM (NMBR).
  • Chemical formula C32H35N5O5; molecular weight 569.65 g/mol.
  • High purity solid (98.87%), available in solid and DMSO solution formats.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.